MedPath

Study for the assessment of clinical non-inferiority and tolerability of different conjugated estrogen vaginal cream ESTROGENON (Sanval Comercio e Industria Ltda) versus PREMARIN (Wyeth Industria Farmaceutica Ltda) in women post menopause.

Phase 3
Conditions
Study with the purpose of check clinical non-inferiority and tolerance of two vaginal cream based on the conjugated estrogen manufactured by different manufacturers.
Women in post menopause with indications for estrogen replacement therapy.
Reproductive Health and Childbirth - Menstruation and menopause
Registration Number
ACTRN12610000103066
Lead Sponsor
Sanval Comercio e Industria Ltda.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
Female
Target Recruitment
66
Inclusion Criteria

Women in post menopause with indications for estrogen replacement therapy

Exclusion Criteria

Patients with contraindications for estrogen use

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Endometrium thickness - test used: transvaginal ultrasound exam[90 days following randomization]
Secondary Outcome Measures
NameTimeMethod
Alterations in clinical examination (gynecological) - Citology[90 days following randomization]
© Copyright 2025. All Rights Reserved by MedPath